The Traderszone Network

19 July, 2014 by The TZ Newswire Staff Comments Off on NewsWatch: Here’s your second-half playbook for stocks

NewsWatch: Here’s your second-half playbook for stocks

The year got off to a slow start, but that’s not a reason to be concerned, writes Tim Clift.
read more

19 July, 2014 by The TZ Newswire Staff Comments Off on How Michele Ferrero Made His Billions

How Michele Ferrero Made His Billions

Learn how Michele Ferrero, the mind behind Ferrero Group, managed to build a confectionary empire out of one market opportunity.

read more

19 July, 2014 by The TZ Newswire Staff Comments Off on Cheap Credit Will Sink Us Again

Cheap Credit Will Sink Us Again

The past few years have been a great data driven example of finance not being a science.  Globally, central banks have done everything from bailing out institutions, displaying a complete lack of discretion when it comes to disbursing cash (GOP leader’s wife received 2009 bailout funds), and we have also seen attempts globally to devalue currency.

Talking heads have parroted three points lately:

read more

19 July, 2014 by The TZ Newswire Staff Comments Off on China Will Make India’s Coal Habit Even Worse

China Will Make India’s Coal Habit Even Worse

There’s so much coal chasing Chinese demand that coal prices have fallen, and that’s making India’s demand for the fuel even greater.

read more

19 July, 2014 by The TZ Newswire Staff Comments Off on Hoisington: 30Y Treasury Bonds Are Undervalued

Hoisington: 30Y Treasury Bonds Are Undervalued

Via Hoisington Investment Management,

read more

19 July, 2014 by The TZ Newswire Staff Comments Off on Accusations fly as bodies fester at MH17 crash site

Accusations fly as bodies fester at MH17 crash site

Ukraine accused pro-Moscow rebels on Saturday of destroying evidence to cover up their guilt in the shooting down of MH17.

19 July, 2014 by The TZ Newswire Staff Comments Off on The Implications of Obesity as a Disability in Europe

The Implications of Obesity as a Disability in Europe

Despite rising obesity in Europe, the EU has yet to approve weight loss drugs from Arena (ARNA), Vivus (VVUS), or Orexigen (OREX).

read more